Project Grant HT94252510950
Award Date 10/1/25
Completion Date 9/30/27
Dollars Obligated $156K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- This $894,125 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at the Washington University in St. Louis to understand and target epigenetic vulnerabilities in NF-1-associated malignant peripheral nerve sheath tumors (MPNSTs). The award, with a period of performance from July 2025 to July 2028, will fund innovative biomedical research aimed at transforming healthcare for military service members, veterans,...
- The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
- The Defense Health Agency awarded a $4,876,076 Project Grant to The Washington University in University City, Missouri for the period of August 1, 2025 to July 31, 2029. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports the development of a novel point-of-care multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome and sepsis. This research aims to transform healthcare for military service members,...
- The University of Minnesota will leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors under a $548,892 project grant from the Defense Health Agency. The grant was awarded on August 1, 2023 with a completion date of July 31, 2026. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through...
- This Project Grant award from the Department of the Army Medical Command totals $894,263 to The Washington University for the period of September 1, 2022 through August 31, 2025. The award supports research under the Military Medical Research and Development program (CFDA 12.420) to further understanding of the pathogenesis and prognostication of malignant peripheral nerve sheath tumors (MPNSTs) associated with Neurofibromatosis type 1 (NF1). Under the award, The Washington University will...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $256,208 to The Washington University in University City, MO to conduct research on "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma". The 2-year award, effective from August 1, 2025 to July 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service...
- The U.S. Defense Health Agency awarded a $500,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University in St. Louis, Missouri. The grant, awarded on August 1, 2025, supports a 2-year research project titled "Harnessing Single-Cell T Cell-Receptor Sequencing to Accelerate Diagnosis in Inflammatory Arthritis." This research aims to transform healthcare for military service members, veterans, and the broader public through...
- This $109,632 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Radar Therapeutics Inc. in Berkeley, CA to investigate selective translation of LNP-delivered mRNA for precision therapeutics in rare cancers including peripheral T-cell lymphoma. The award period runs from August 1, 2025 to July 31, 2026. The research aims to transform healthcare for military service members, veterans, and the broader...
- The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...